Women’s Wear Daily
04.20.2014

Financial

Beauty

Financial

Page 5 of 1326
beiersdorf, nivea, eucerin, tesa, la prairie, stefan heidenreich

Beiersdorf 2013 Profits Rise 11.9%

The German maker of Nivea, Eucerin and La Prairie forecast above-market growth for 2014.

Givaudan in Talks to Acquire Soliance

Terms of the deal for the French cosmetics ingredients supplier, owned by ARD, were not disclosed.

Sheri McCoy, Avon, Consumer Analyst Group of New York, Procter & Gamble, A.G. Lafley, L’Oréal, Jean-Paul Agon, turnaround, conference, CAGNY

Avon, P&G and L'Oréal Execs Sound Off at CAGNY

Sheri McCoy, Avon’s chief executive officer, gave the most detailed account to date of her turnaround plan at the conference on Thursday.

Avon and Coty Plan Brazilian Deal

The two beauty firms have signed a letter of intent.

Henkel Q4 Profits Dip 8%

Group sales declined 3.7 percent to 3.85 billion euros, or $5.24 billion.

Shiseido Sells Carita, Decléor to L’Oréal

The Japanese company is selling the brands for a total of 227.5 million euros, or $312.93 million at current exchange rates.

Victoria's Secret and Bath & Body Works File Lawsuit

Preferred Fragrance and Fragrance Acquisitions, as well as Izriel Polatsek, ceo, have been sued for trade dress and trademark infringement.

Newsletters
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

Publications

ArticleFinder

Beauty


Choose By

Clear

How it works

Close

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.


Or